Prognostic Value of Putative Circulating Cancer Stem Cells in Patients Undergoing Hepatic Resection for Colorectal Liver Metastasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic Value of Putative Circulating Cancer Stem Cells in Patients Undergoing Hepatic Resection for Colorectal Liver Metastasis

Published:2011-11-10 Issue:2 Volume:19 Page:402-408
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Pilati Pierluigi,Mocellin Simone,Bertazza Loris,Galdi Francesca,Briarava Marta,Mammano Enzo,Tessari Emanuela,Zavagno Giorgio,Nitti Donato

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-011-2132-2.pdf

Reference42 articles.

1. Primrose JN. Surgery for colorectal liver metastases. Br J Cancer. 2010;102:1313–8.

2. Lise M, Mocellin S, Pilati P, Nitti D. Colorectal liver metastasis: towards the integration of conventional and molecularly targeted therapeutic approaches. Front Biosci. 2005;10:3042–57.

3. Kemeny N. The management of resectable and unresectable liver metastases from colorectal cancer. Curr Opin Oncol. 2010;22:364–73.

4. Mayo SC, Pawlik TM. Current management of colorectal hepatic metastasis. Expert Rev Gastroenterol Hepatol. 2009;3:131–44.

5. Power DG, Kemeny NE. Role of adjuvant therapy after resection of colorectal cancer liver metastases. J Clin Oncol. 2010;28:2300–9.

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Colorectal Cancer Stem Cell Biomarkers: Biological Traits and Prognostic Insights;Current Pharmaceutical Design;2024-05

2. Presence of CD44v9-Expressing Cancer Stem Cells in Circulating Tumor Cells and Effects of Carcinoembryonic Antigen Levels on the Prognosis of Colorectal Cancer;Cancers;2024-04-19

3. RSPO2 as Wnt signaling enabler: Important roles in cancer development and therapeutic opportunities;Genes & Diseases;2024-03

4. Circulating Cancer Stem Cells; Role in Cancer Prognosis, Metastasis and Targeted Therapy;Comprehensive Hematology and Stem Cell Research;2024

5. Can CD133 Be Regarded as a Prognostic Biomarker in Oncology: Pros and Cons;International Journal of Molecular Sciences;2023-12-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3